U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
cudarolimab [INN]
Preferred Name English
CUDAROLIMAB
INN  
Official Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TNFRSF4 (TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 4, ACT35, OX40, CD134)), HOMO SAPIENS MONOCLONAL ANTIBODY
Common Name English
Cudarolimab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD134 ANTIGEN) (HUMAN MONOCLONAL IBI101 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IBI101 .KAPPA.-CHAIN, DIMER
Common Name English
IBI-101
Code English
IBI101
Code English
Code System Code Type Description
INN
11200
Created by admin on Wed Apr 02 01:30:58 GMT 2025 , Edited by admin on Wed Apr 02 01:30:58 GMT 2025
PRIMARY
NCI_THESAURUS
C158507
Created by admin on Wed Apr 02 01:30:58 GMT 2025 , Edited by admin on Wed Apr 02 01:30:58 GMT 2025
PRIMARY
SMS_ID
300000023643
Created by admin on Wed Apr 02 01:30:58 GMT 2025 , Edited by admin on Wed Apr 02 01:30:58 GMT 2025
PRIMARY
FDA UNII
DT958C4NWR
Created by admin on Wed Apr 02 01:30:58 GMT 2025 , Edited by admin on Wed Apr 02 01:30:58 GMT 2025
PRIMARY
CAS
2244739-29-3
Created by admin on Wed Apr 02 01:30:58 GMT 2025 , Edited by admin on Wed Apr 02 01:30:58 GMT 2025
PRIMARY
ACTIVE MOIETY
CUDAROLIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966